Published in

Elsevier, The Lancet Oncology, 11(19), p. 1459-1467, 2018

DOI: 10.1016/s1470-2045(18)30686-7

Links

Tools

Export citation

Search in Google Scholar

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Journal article published in 2018 by Linda M. Henricks, Carin A. T. C. Lunenburg, Femke M. de Man, Didier Meulendijks, Geert W. J. Frederix, Emma Kienhuis, Geert-Jan Creemers, Arnold Baars, Vincent O. Dezentjé, Alexander L. T. Imholz, Frank J. F. Jeurissen, Johanna E. A. Portielje ORCID, Rob L. H. Jansen, Paul Hamberg, Albert J. ten Tije and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO